A Review of the Literature on Culture-Negative Periprosthetic Joint Infection: Epidemiology, Diagnosis and Treatment
- PMID: 28854760
- PMCID: PMC5596406
- DOI: 10.5792/ksrr.16.034
A Review of the Literature on Culture-Negative Periprosthetic Joint Infection: Epidemiology, Diagnosis and Treatment
Abstract
Purpose: The prevalence of periprosthetic joint infection (PJI) has increased with the increasing incidence of arthroplasty surgery. Considering identification of causative microorganisms is crucial for treatment of PJI, culture-negative (CN) PJI is a significant clinical issue. The purpose of the present study is to describe epidemiology, diagnosis and treatment of CN PJI based on review of the literature to help prevent delayed diagnosis and improve clinical outcomes of CN PJI.
Methods: MEDLINE, EMBASE, Cochrane Library and Scopus databases were searched for articles on CN PJI. Only clinical studies written in English were included. Basic science studies, letters to the editor, case reports and review articles on PJI were excluded.
Results: Seven studies were included in this study. The prevalence of CN PJI ranged from 0% to 42.1%. The major risk factors for CN PJI were prior antibiotic use and presence of postoperative wound drainage. Vancomycin and cephalosporins were the most commonly used antibiotics for CN PJI. Two-stage revision arthroplasty followed by 6 weeks of antibiotic therapy produced the most successful treatment outcomes.
Conclusions: In most clinical studies on CN PJI, a definite diagnostic method for identifying causative microorganisms or optimal treatment strategy for CN PJI were not clearly described. Therefore, further studies are needed to establish standard diagnostic methods for identifying infecting organisms and treatment strategies for CN PJI.
Keywords: Arthroplasty; Culture; Infection; Review.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Culture-negative periprosthetic joint infection: prevalence, aetiology, evaluation, recommendations, and treatment.Int Orthop. 2020 Jul;44(7):1255-1261. doi: 10.1007/s00264-020-04627-5. Epub 2020 May 24. Int Orthop. 2020. PMID: 32449042
-
Do Culture-Negative Periprosthetic Joint Infections Have a Worse Outcome Than Culture-Positive Periprosthetic Joint Infections? A Systematic Review and Meta-Analysis.Biomed Res Int. 2018 Jul 12;2018:6278012. doi: 10.1155/2018/6278012. eCollection 2018. Biomed Res Int. 2018. PMID: 30112408 Free PMC article.
-
Long-term clinical outcome of two-stage revision surgery for infected hip arthroplasty using cement spacer: Culture negative versus culture positive.J Orthop Surg (Hong Kong). 2018 Jan-Apr;26(1):2309499017754095. doi: 10.1177/2309499017754095. J Orthop Surg (Hong Kong). 2018. PMID: 29366392
-
Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty.Open Orthop J. 2016 Nov 30;10:615-632. doi: 10.2174/1874325001610010615. eCollection 2016. Open Orthop J. 2016. PMID: 28503214 Free PMC article.
-
Effective treatment of single-stage revision using intra-articular antibiotic infusion for culture-negative prosthetic joint infection.Bone Joint J. 2020 Mar;102-B(3):336-344. doi: 10.1302/0301-620X.102B3.BJJ-2019-0820.R1. Bone Joint J. 2020. PMID: 32114816
Cited by
-
Challenging Diagnostics of Biofilm Associated Periprosthetic Infection in Immunocompromised Patient: A Clinical Case.Open Access Maced J Med Sci. 2019 Mar 13;7(5):786-790. doi: 10.3889/oamjms.2019.180. eCollection 2019 Mar 15. Open Access Maced J Med Sci. 2019. PMID: 30962840 Free PMC article.
-
Effects of COVID-19 on short-term outcomes of hip arthroplasty: a multicenter, retrospective, propensity score matched study.BMC Musculoskelet Disord. 2025 Jan 9;26(1):36. doi: 10.1186/s12891-024-08268-2. BMC Musculoskelet Disord. 2025. PMID: 39789558 Free PMC article.
-
The Effectiveness of Metagenomic Next-Generation Sequencing in the Diagnosis of Prosthetic Joint Infection: A Systematic Review and Meta-Analysis.Front Cell Infect Microbiol. 2022 Jun 10;12:875822. doi: 10.3389/fcimb.2022.875822. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35755833 Free PMC article.
-
Serum CD64 as a Marker for Chronic Periprosthetic Joint Infection.Arthroplast Today. 2023 Apr 21;21:101138. doi: 10.1016/j.artd.2023.101138. eCollection 2023 Jun. Arthroplast Today. 2023. PMID: 37151405 Free PMC article.
-
Low accuracy in preoperative tissue biopsies for diagnosing chronic periprosthetic joint infection: an observational retrospective single-centre study.J Int Med Res. 2023 Jun;51(6):3000605231158972. doi: 10.1177/03000605231158972. J Int Med Res. 2023. PMID: 37389568 Free PMC article.
References
-
- Parvizi J, Ghanem E, Menashe S, Barrack RL, Bauer TW. Periprosthetic infection: what are the diagnostic challenges? J Bone Joint Surg Am. 2006;88(Suppl 4):138–47. - PubMed
-
- Ghanem E, Parvizi J, Clohisy J, Burnett S, Sharkey PF, Barrack R. Perioperative antibiotics should not be withheld in proven cases of periprosthetic infection. Clin Orthop Relat Res. 2007;461:44–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources